Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Many believe tumor profiling will benefit present treatment
Marron et al. JCO Precis Oncol. 2019 Jan 22. doi: 10.1200/PO.18.00176.
Key clinical point: Although most cancer patients and parents of cancer patients understand that genomic tumor profiling research aims to improve care for future patients, many also believe that the process will benefit present treatment.
Major finding: Fifty-five percent of respondents demonstrated comprehensive understanding the purpose of genomic tumor profiling research.
Study details: A survey of 45 cancer patients and parents of cancer patients conducted at four academic treatment centers.
Disclosures: The study was funded by Hyundai Hope on Wheels, the Friends for Life Foundation, the Gillmore Fund, National Institutes of Health, and others. The investigators reported financial affiliations with Merck, Millennium, Novartis, Roche, Amgen, and others.
Marron et al. JCO Precis Oncol. 2019 Jan 22. doi: 10.1200/PO.18.00176.